Eli Lilly Stock Jumps After Earnings Beat. Weight-Loss Drugs Are Driving Gains.
The pharmaceutical company reported adjusted earnings of $2.58 a share for the first quarter of 2024, up 59% from the same period a year earlier. Revenue rose 26% to $8.77 billion.